IUS president Donald Trump has unveiled sweeping new trade measures, announcing a 100% tariff on branded and patented pharmaceutical imports beginning 1 October 2025, unless manufacturers are actively building production plants in the country. The announcement, made on his social media platform Truth Social, has sparked concern in global markets and drawn particular attention in India, whose pharmaceutical industry relies heavily on exports to America. “Starting 1 October 2025, we will be imposing a 100% tariff on any branded or patented pharmaceutical product, unless a company is building their pharmaceutical manufacturing plant in America,” president Trump declared. He clarified that 'building' would be defined as 'breaking ground' or 'under construction', adding that firms already

See Full Page